Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
- PMID: 36001875
- DOI: 10.1080/00952990.2022.2111685
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Abstract
Background: Kratom (Mitragyna speciosa Korth.) products are increasingly endorsed for self-management of multiple ailments, including as opioid substitution. The FDA has expressed that there is no evidence to indicate that this botanical is safe or effective for any medical use.Objective: We systematically review the current state of the literature concerning the impact of kratom and its alkaloids in all paradigms that involve opioids.Methods: A keyword search of online literature databases identified 16 preclinical studies, 25 case reports, and 10 observational studies meeting our pre-selected criteria.Results: All rodent models support alkaloids' action on opioid receptors, translating in their ability to mitigate opioid withdrawal. Some studies found mitragynine (MG) to have less reinforcing properties than morphine, and possessing tolerance-sparing properties when coadministered with morphine. Two studies that assessed 7-hydroxymitragynine (7OHMG) found it to substitute for morphine with potential for tolerance and dependence. Aside from addiction development, case reports outline a variety of confounding toxicities. Ten surveys of users, some conducted with assistance from pro-kratom lobbying organizations, find a high self-reported efficacy as an opioid substitute, with minimal reported adverse effects.Conclusion: With no reported controlled human clinical trials, in the light of rising concerns surrounding kratom's liabilities, there is insufficient evidence to allow any conclusions to be drawn. Case reports and observational studies carry significant bias toward harm and efficacy, respectively. Existing animal studies are heterogeneous in methodology and ultimately findings, with concern for interspecies variability and human translatability. Further research should investigate the safety and efficacy of using kratom alkaloids as opioid substitutes.
Keywords: Kratom; Mitragyna; addiction; heroin; morphine; opioid; systematic review.
Similar articles
-
Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature.Food Chem Toxicol. 2024 Oct;192:114913. doi: 10.1016/j.fct.2024.114913. Epub 2024 Aug 10. Food Chem Toxicol. 2024. PMID: 39134135 Review.
-
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.Cell Mol Neurobiol. 2021 Jul;41(5):1131-1143. doi: 10.1007/s10571-020-01034-7. Epub 2021 Jan 12. Cell Mol Neurobiol. 2021. PMID: 33433723 Free PMC article.
-
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.Addict Biol. 2019 Sep;24(5):874-885. doi: 10.1111/adb.12639. Epub 2018 Jun 27. Addict Biol. 2019. PMID: 29949228
-
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).J Clin Pharmacol. 2022 May;62(5):577-593. doi: 10.1002/jcph.2001. Epub 2022 Jan 5. J Clin Pharmacol. 2022. PMID: 34775626 Review.
-
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.J Ethnopharmacol. 2020 Mar 1;249:112462. doi: 10.1016/j.jep.2019.112462. Epub 2019 Dec 7. J Ethnopharmacol. 2020. PMID: 31816368
Cited by
-
Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice.Pharmacol Rep. 2023 Aug;75(4):937-950. doi: 10.1007/s43440-023-00498-w. Epub 2023 May 27. Pharmacol Rep. 2023. PMID: 37243887
-
Kratom as a potential substance use disorder harm reduction agent.Front Public Health. 2024 May 30;12:1416689. doi: 10.3389/fpubh.2024.1416689. eCollection 2024. Front Public Health. 2024. PMID: 38873312 Free PMC article. Review.
-
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.Subst Abuse Treat Prev Policy. 2023 Apr 11;18(1):21. doi: 10.1186/s13011-023-00531-4. Subst Abuse Treat Prev Policy. 2023. PMID: 37041624 Free PMC article.
-
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.Front Psychiatry. 2024 May 23;15:1411964. doi: 10.3389/fpsyt.2024.1411964. eCollection 2024. Front Psychiatry. 2024. PMID: 38846916 Free PMC article. No abstract available.
-
Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples.Basic Clin Pharmacol Toxicol. 2025 Feb;136(2):e14117. doi: 10.1111/bcpt.14117. Basic Clin Pharmacol Toxicol. 2025. PMID: 39806572 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources